Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:409209.
doi: 10.1155/2014/409209. Epub 2014 Dec 17.

Perampanel and challenging behaviour in intellectual disability and epilepsy: a management dilemma

Affiliations

Perampanel and challenging behaviour in intellectual disability and epilepsy: a management dilemma

Emily Dolton et al. Case Rep Psychiatry. 2014.

Abstract

We describe a case of a patient with a diagnosis of moderate learning disability with challenging behaviour and treatment refractory epilepsy. Antiepileptics can increase challenging behaviour; however, antipsychotics can provoke seizures. This results in a difficult balance for patient care. Due to worsening seizures, the patient was prescribed perampanel. This increased her aggression and agitation resulting in admission. We trialled four antipsychotic drugs to reduce her challenging behaviour, two of which worsened her seizures. It was necessary to continue antiepileptic medication to maintain adequate seizure control. However, the resulting uncontrolled challenging behaviour persisted, meaning she was unable to return to her family home on discharge. This case emphasises the difficult scenario clinician's encounter when balancing the use of antipsychotics and antiepileptics. The case demonstrates the significant functional loss due to challenging behaviour, balanced against controlling life threatening seizures.

PubMed Disclaimer

References

    1. Erhorn S. Perampanel for epilepsy, Newcastle, UK, NHS Regional Drug & Therapeutics Centre, 2012, http://www.netag.nhs.uk/files/appraisal-reports/Perampanel%20-%20NETAG%2....
    1. FDA . Fycompa Full Prescribing Information. Silver Spring, Md, USA: FDA; 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202834lbl.pdf.
    1. Coulter D. L. Epilepsy and mental retardation: an overview. American Journal on Mental Retardation. 1993;98:1–11. - PubMed
    1. McClintock K., Hall S., Oliver C. Risk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic study. Journal of Intellectual Disability Research. 2003;47(6):405–416. doi: 10.1046/j.1365-2788.2003.00517.x. - DOI - PubMed
    1. Kiernan C., Reeves D., Alborz A. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. Journal of Intellectual Disability Research. 1995;39(4):263–274. doi: 10.1111/j.1365-2788.1995.tb00518.x. - DOI - PubMed

LinkOut - more resources